Investing

Friday's Top Biotech & Medical Stocks

by H.S. Ayoub
BioHealth Investor.com

Biotechnology

GENETIC TECH SPON [GENE] +12.60%
CORCEPT THERAPEUTICS [CORT] +10.22%
MEDAREX INC [MEDX] +9.28%
CHELSEA THERAPEUTICS [CHTP] +6.16%
BOSTON LIFE SCIENCES [BLSI] +5.78%

Diagnostic Substances

PALATIN TECH INC [PTN] +8.11%
ISTA PHARMACTLS [ISTA] +6.80%
GENE LOGIC INC [GLGC] +4.70%
ROSETTA GENOMICS LTD [ROSG] +3.39%
PONIARD PHARMA [PARD] +3.04%

Drug Delivery

IOMED INC [IOX] +31.16%
EMISPHERE TECH [EMIS] +9.57%
ELAN CP PLC ADR [ELN] +8.36%
COLUMBIA LABS INC [CBRX] +2.62%
MATRIXX INITIATVS [MTXX] +1.93%

Drug Manufacturers

PROTALEX INC [PRTX.OB] +19.20%
OREXIGEN THERAPEUTIC [OREX] +11.52%
AVANIR PHARMACEUTICL [AVNR] +6.90%
OSCIENT PHARMACEUT [OSCI] +6.78%
YM BIOSCIENCES INC [YMI] +6.21%

Drug Related Products

ZILA INC [ZILA] +11.04%
IMAGENETIX INC [IAGX.OB] +8.33%
PACIFICHEALTH LABS [PHLI.OB] +5.00%
AUXILIUM PHARMACEUT [AUXL] +3.83%
PRESTIGE BRAND HLGS [PBH] +2.29%

Generic Drugs

PHARMACUTICAL CO [PRX] +3.10%
WATSON PHARMACEUTCLS [WPI] +1.41%
BARR PHARMA INC [BRL] +0.37%
MYLAN LABS INC [MYL] +0.10%

Medical Appliances & Equipment

BSD MEDICAL CORP [BSM] +10.15%
VISION SCIENCES IN [VSCI] +8.62%
HEALTHTRONICS INC [HTRN] +8.15%
MEDICALCV INC [MCVI.OB] +6.67%
SPECTRANETICS CP T [SPNC] +5.83%

Medical Instruments & Supplies

TUTOGEN MEDICAL INC [TTG] +7.93%
VYTERIS HOLDINGS NV [VYHN.OB] +7.69%
MINDRAY MEDICAL INTL [MR] +6.51%
ISORAY INC [ISR] +6.41%
CARDIOTECH INTL [CTE] +5.47%

Medical Laboratories & Research

NATL DENTEX CP [NADX] +4.38%
GENOMIC HEALTH, INC. [GHDX] +2.77%
AETERNA ZENTARIS [AEZS] +2.22%
ERESEARCHTECHNOLOG [ERES] +1.97%
PSYCHEMEDICS NEW [PMD] +1.31%

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here
you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.


Click here
to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.